What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
about
Molecular methods in the laboratory diagnosis of sexually transmitted infectionsLeucocyte esterase dip-stick test as a point-of-care diagnostic for urogenital chlamydia in male patients: A multi-center evaluation in two STI outpatient clinics in Paramaribo and AmsterdamPoint of care diagnostics for sexually transmitted infections: perspectives and advancesRapid detection and strain typing of Chlamydia trachomatis using a highly multiplexed microfluidic PCR assay.What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing?Clinical evaluation of the OneStep Gonorrhea RapiCard InstaTest for detection of Neisseria gonorrhoeae in symptomatic patients from KwaZulu-Natal, South AfricaAcceptability of self-testing for trichomoniasis increases with experienceDevelopment of a microwave-accelerated metal-enhanced fluorescence 40 second, <100 cfu/ml point of care assay for the detection of Chlamydia trachomatisPerceptions on Point-of-Care Tests for Sexually Transmitted Infections - Comparison between Frontline Clinicians and Professionals in Industry.Minding the Gap: An approach to determine critical drivers in the development of Point of Care diagnostics.STI management and control in North America IUSTI region.Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical settingPOINT-OF-CARE HEMATOLOGY AND COAGULATION TESTING IN PRIMARY, RURAL EMERGENCY, AND DISASTER CARE SCENARIOS.Blind evaluation of the microwave-accelerated metal-enhanced fluorescence ultrarapid and sensitive Chlamydia trachomatis test by use of clinical samples.Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men.An evaluation of the SD Bioline HIV/syphilis duo test.A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples
P2860
Q26782561-4B938AA3-4E2F-4E29-8399-4E6B1973D20EQ29353593-E5ED6225-7246-486F-95DC-5C693BBB02A0Q30436304-948C87A9-E76C-4DEC-9D3F-49FE024254C8Q33746002-3568CFB6-B55E-4203-90B1-1E453EB04BF9Q33895091-85C78BE9-D53E-4E78-95DB-AEDE363619D7Q35193222-1FADB902-195D-452A-A068-7621137A702EQ35275968-36BC04BE-506E-4B34-8BF0-4D1C0564ADFAQ35564939-2A89ADD6-4BBD-4AD3-A603-23428F7096ABQ36116147-0AADB222-B216-49D0-AB70-163D09DCC73FQ36176694-D3FD111F-52EA-495C-8466-0448ABF9C6BAQ36650578-0C4D7097-8E67-48EB-99C6-20AD566CE87DQ36900768-ED2CAF31-60F4-45B1-AEAF-DA2516074FE5Q36989709-9BFD5AF3-BABC-492F-9AB9-8C1FD0A7A743Q37125196-3284B405-DFF0-45E0-AC29-77AB1EA8E9FEQ39019258-03035110-D013-4AFA-8E47-F7B5629496E7Q40153761-182CAD75-76D9-407D-85E1-52CCB43F50E4Q49359551-AB45408D-C866-4B46-A4FF-DF4B4C9A4422Q57753948-FF1B3EF4-6479-48DE-84F9-6B39B3369DB0
P2860
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@ast
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@en
type
label
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@ast
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@en
prefLabel
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@ast
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@en
P2860
P1433
P1476
What's the Point? How Point-of-Care STI Tests Can Impact Infected Patients.
@en
P2093
Elizabeth Hesse
Jill Huppert
P2860
P356
10.1097/POC.0B013E3181D2D8CC
P577
2010-03-01T00:00:00Z